Formycon

Gedeon Richter Becomes Strategic Investor of Formycon

Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9.08% of Formycon’s share capital, which corresponds to €82.84 million.

Topics • Technology

Chances and Hurdles for Biosimilars

Top-Feature

Concept Heidelberg

API Manufacturing

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

SchüllerConsulting

Formycon

Gedeon Richter Becomes Strategic Investor of Formycon

Chances and Hurdles for Biosimilars

Top-Feature

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Brenntag Downsizes Management Board, Retains Both Divisions

20 Years of CHEManager International

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

API Manufacturing

Special Issue

Circular Plastics Economy

Newsletter & e-edition